Abciximab reduces mortality in diabetics following percutaneous coronary intervention. [electronic resource]
Producer: 20000331Description: 922-8 p. digitalISSN:- 0735-1097
- Abciximab
- Adult
- Aged
- Angina, Unstable -- mortality
- Angioplasty, Balloon, Coronary
- Antibodies, Monoclonal -- adverse effects
- Diabetic Angiopathies -- mortality
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Female
- Follow-Up Studies
- Humans
- Immunoglobulin Fab Fragments -- adverse effects
- Male
- Middle Aged
- Myocardial Infarction -- mortality
- Platelet Aggregation Inhibitors -- adverse effects
- Platelet Glycoprotein GPIIb-IIIa Complex -- antagonists & inhibitors
- Randomized Controlled Trials as Topic
- Recurrence
- Risk Factors
- Stents
- Survival Rate
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.